Ownership history in Vestal Point Capital, LP · 7 quarters on record
This page tracks every 13F SEC filing in which Vestal Point Capital, LP reported a position in Day One Biopharmaceuticals Inc (DAWN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 5,200,000 | +2,525,000 | +94.4% | 1.65% | $48.5M | $9.32 |
| 2025 Q3 | REDUCED | 2,675,000 | -325,000 | -10.8% | 0.85% | $18.9M | $7.05 |
| 2025 Q2 | ADDED | 3,000,000 | +401,873 | +15.5% | 1.03% | $19.5M | $6.50 |
| 2025 Q1 | ADDED | 2,598,127 | +1,158,127 | +80.4% | 1.47% | $20.6M | $7.93 |
As of 2025 Q4 — sorted by position size